Understanding Ovarian Cancer Recurrence Through Gene Expression
Author Information
Author(s): Laios Alexandros, O'Toole Sharon A, Flavin Richard, Martin Cara, Ring Martina, Gleeson Noreen, D'Arcy Tom, McGuinness Eamonn PJ, Sheils Orla, Sheppard Brian L, O' Leary John J
Primary Institution: Trinity College Dublin
Hypothesis
Can primary and recurrent ovarian tumors be distinguished based on their gene expression profiles?
Conclusion
The study identified distinct gene expression patterns between primary and recurrent ovarian cancers, suggesting potential biomarkers for recurrence.
Supporting Evidence
- 907 genes were differentially expressed between primary and recurrent samples.
- 182 genes remained significant after applying a false discovery rate.
- High concordance was observed between TaqMan® and microarray experiments.
Takeaway
This study looked at how ovarian cancer comes back after treatment and found specific genes that might help doctors tell if a cancer will return.
Methodology
The study used cDNA microarray experiments to analyze gene expression in primary and recurrent ovarian tumors.
Potential Biases
Potential bias due to the small sample size and specific patient demographics.
Limitations
The study focused on a specific histological subtype and may not generalize to all ovarian cancer types.
Participant Demographics
Cohort 1 included 5 primary and 5 recurrent serous papillary adenocarcinomas; mean age was 62.6 for primary and 52.4 for recurrent.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website